Royalty Pharma

Biotechnology · Business & SME Lending

Overview

Royalty Pharma is a publicly listed investor that is the largest buyer of biopharmaceutical royalties and a major funder of innovation in the life sciences. It acquires royalty interests in approved and late-stage therapies and provides synthetic royalty, debt and equity funding to biotech and pharmaceutical companies, universities and research institutions. The company was founded in 1996 by Pablo Legorreta, is headquartered in New York and trades on the Nasdaq exchange.

Visa sponsorship

#5,755 of 8,998 sponsors
United StatesUS 1
1
H-1B filings in 12 months
$178k
Median offered salary
0
Open roles in United States
Who they sponsor
Financial and investment analysts
1
The salary offered for each occupationVisa pass · 90 credits
In the register as Royalty Pharma, LLC, New York, NY
Other sponsors in the same field
Blue Owl Capital 9 filingsOaktree Capital Management 3 filingsCastlelake 3 filingsSilver Point Capital 3 filings
Alert me
US Department of Labor · latest filing Apr 30, 2026 · Visa details by country

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Paladin Capital GroupVia a fund
67 portfolio companies: Human Security, Zerve, Virtuoso QA and 64 more
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York United States
HQ
Stay up to date
50-200 est. staff
110 E 59th Street FL 33, New York, NY 10022
company site